The price gap — and why it exists
Branded GLP-1 medications are among the most expensive drugs in the world. Wegovy costs approximately $1,349/month and Zepbound $1,059/month at list price — driven by the enormous R&D investment behind them and the absence of generic competition. Novo Nordisk and Eli Lilly hold patents that prevent generic versions from entering the market until the mid-2030s at the earliest.
Compounding pharmacies can legally prepare copies of medications under specific circumstances — primarily when a drug is on the FDA shortage list. When semaglutide was declared in shortage (2022–2025), this opened a large window for compounded versions at dramatically lower prices. The FDA resolving the semaglutide shortage in early 2025 has largely closed that window for semaglutide, but tirzepatide compounding remains more broadly available.
Important 2025–2026 update: The FDA declared the semaglutide shortage resolved in early 2025. This legally restricts most compounding pharmacies from producing semaglutide copies. Many telehealth platforms pivoted to FDA-approved Wegovy or to tirzepatide compounding. If you're seeking compounded semaglutide in 2026, verify availability in your state — it varies significantly and is actively changing.
All your options compared
| Option | Monthly cost | FDA approved | Available |
|---|---|---|---|
| Wegovy (branded sema) | $1,349 | Yes ✓ | Yes |
| Wegovy + savings card (commercial ins.) | $0–225 | Yes ✓ | Yes — if insured |
| Zepbound (branded tirz) | $1,059 | Yes ✓ | Yes |
| Zepbound LillyDirect vials | $349 | Yes ✓ | Yes — self-pay |
| Compounded semaglutide | $99–350 | No ✗ | Restricted in most states |
| Compounded tirzepatide | $250–500 | No ✗ | More broadly available |
Is compounded medication as effective?
Compounded semaglutide and tirzepatide contain the same active ingredient as their branded counterparts — but quality, concentration, and purity can vary significantly between compounding pharmacies. Key differences:
- No FDA manufacturing oversight: Branded drugs undergo rigorous FDA facility inspections; compounding pharmacies have less oversight
- No clinical trial data: Branded drugs have multi-year Phase 3 efficacy and safety data; compounded versions do not
- Salt form differences: Some compounded products use semaglutide sodium or acetate salts rather than the base form used in Wegovy — these may have different absorption profiles
- Reconstitution required: Many compounded versions come as powder or concentrated solution requiring proper preparation
Bottom line: For many patients, compounded GLP-1 medications from reputable 503B pharmacies have worked well. But the lack of FDA oversight means quality varies, and availability is now legally restricted for semaglutide. If cost is the driving factor, Zepbound vials via LillyDirect ($349/month) offer an FDA-approved middle ground.